BONVENTURE and Ship2B Ventures have invested in the Berlin-based digital health startup ViViRA to expand its innovative app for treating back pain across Germany.

Target Company Overview

ViViRA, a Berlin-based digital health startup, specializes in providing innovative therapy solutions for individuals suffering from back pain. Their flagship product, the ViViRA app, offers a prescription-based digital therapeutic platform designed to facilitate movement therapy at home, thereby addressing musculoskeletal disorders. With a growing number of patients utilizing the application, ViViRA aims to enhance its services by expanding its market reach across Germany and developing additional digital solutions.

According to the Robert Koch Institute, approximately 60% of Germans experience back pain at least once a year, making it a leading cause of work-related disability and premature retirement. The current healthcare provision for back pain patients indicates significant shortcomings, as only 50% of those needing physiotherapy receive the appropriate prescriptions, according to BARMER.

Industry Overview in Germany

The digital health sector in Germany is experiencing a significant transformation, especially since the introduction of the Digital Healthcare Act (DVG) in late 2019, which encourages the integration of digital health applications int

View Source

Similar Deals

Holland Capital Semalytix

2025

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Germany
WMS ROTOP Pharmaka GmbH

2025

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Germany
GENUI and SHS Capital ROTOP Pharmaka GmbH

2025

Growth Equity & Expansion Capital In-Vivo Diagnostic & Testing Substances Germany
Great Point Partners Lyocontract GmbH

2024

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Germany
ARCHIMED PlasmidFactory

2023

Growth Equity & Expansion Capital Biotechnology & Medical Research (NEC) Germany
ARCHIMED Cube

2023

Growth Equity & Expansion Capital Biotechnology & Medical Research (NEC) Germany

BONVENTURE, Ship2B Ventures

invested in

ViViRA

in 2024

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert